Medifast Inc (MED-N) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr06/2026	Next Qtr09/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$-0.68	$-0.60	$-1.97	$-1.89
Number of Estimates	1	1	1	1
High Estimate	$-0.68	$-0.60	$-1.97	$-1.89
Low Estimate	$-0.68	$-0.60	$-1.97	$-1.89
Prior Year	$0.04	$-0.21	$-0.82	$-1.97
Growth Rate Est. (year over year)	-1,800.00%	-185.71%	-140.24%	+4.06%

Earnings History - Surprises*

	Qtr Ending03/2026	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025
Reported	$-0.19	$-0.55	$-0.21	$0.04
Estimate	$-0.55	$-0.76	$-0.01	$0.00
Difference	+0.36	+0.21	-0.20	+0.04
Surprise	+65.45%	+27.63%	-2,000.00%	N/A

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

3.00

3 Mths Ago2

3.00

2 Mths Ago2

3.00

1 Mth Ago2

3.00

Current2

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	2	2	2	2

Holds	2	2	2	2

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Thursday’s Insider Report: Multiple executives sell shares in this stock that’s doubled in 2026

Dye & Durham dumps CEO, Tyler Proud now leads company through board committee

number cruncher

Searching for European momentum stocks in a frothy market

Bullish potential on Intact Financial Corp.

Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan

Where will tech stocks go from here?

Six bargain stock picks from hedge fund managers

Gildan stock is down, and looking good